Hypersensitivity Reactions and Anaphylaxis
- Novel therapies with the potential for management of anaphylaxis are currently being investigated. Omalizumab, a monoclonal antibody, has several proposed mechanisms of action, among which includes the rapid reduction of the level of free immunoglobulin E (IgE) in serum. Omalizumab has been approved and used in the treatment of patients with moderate to severe asthma as well as other IgE-mediated allergic disorders. Although there have been case reports regarding its use in anaphylaxis, ongoing research is needs to be performed.
- Another potential therapy for anaphylaxis is methylene blue. It has been show to inhibit the relaxation of smooth muscle in vessels that lead to vasodilation and shock. Animal studies have demonstrated the potential of methylene blue in the prevention of cerebral ischemia associated with anaphylactic shock; however, more research is needed.

.png)








.png)







